LeMaitre to Present at Upcoming Investor Conferences
LeMaitre Vascular announced its participation in two upcoming investor conferences in May 2021. David Roberts, President, will present at the 7th Annual Truist Securities Life Sciences Summit on May 4, 2021. He will also be featured at the UBS Global Healthcare Virtual Conference on May 26, 2021, at 9:00 AM EDT. LeMaitre specializes in devices and services for treating peripheral vascular disease, impacting over 200 million people globally. The firm develops vascular devices tailored for vascular surgeons. More information is available at lemaitre.com.
- None.
- None.
BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.
David Roberts, President, is scheduled to participate in the 7th Annual Truist Securities Life Sciences Summit on Tuesday, May 4, 2021.
He is also scheduled to present at the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021, at 9:00 AM EDT.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com
FAQ
What investor conferences is LeMaitre Vascular participating in May 2021?
Who is representing LeMaitre Vascular at the conferences?
What is the date and time of LeMaitre's presentation at the UBS Virtual Conference?
What does LeMaitre Vascular specialize in?
How many people are affected by peripheral vascular disease globally?
